RIS commits to fund $125,000+ in new sarcoma research

Cancer-cardio-bldg_3-06-2013Rein in Sarcoma and our research team at the University of Minnesota are now processing sarcoma cancer research projects from across the University.

Submitted proposals are currently being reviewed by outside evaluators who will make recommendations to our team and then on to the RIS Board Directors at our annual meeting at the end of January. RIS has committed at least $125,000 in new sarcoma cancer research funding.

In addition, another RIS work group is exploring additional funding options to fund sarcoma cancer research beyond the University of Minnesota Their recommendations are also expected to be presented to the RIS Board at the January 30th meeting.